Chattem
This article was originally published in The Tan Sheet
Executive Summary
Corporate credit rating of "B+" affirmed by S&P Feb. 18. Grade reflects a "stable" outlook based on improved operating performance and cash flow coverage due to planned refinancing. Rating continues to be affected by uncertainty over ongoing PPA and ephedrine litigation, S&P says. Chattem recently initiated another reformulation of Dexatrim without ingredient bitter orange (see story, p. 13)...
|
Corporate credit rating of "B+" affirmed by S&P Feb. 18. Grade reflects a "stable" outlook based on improved operating performance and cash flow coverage due to planned refinancing. Rating continues to be affected by uncertainty over ongoing PPA and ephedrine litigation, S&P says. Chattem recently initiated another reformulation of Dexatrim without ingredient bitter orange (see story, p. 13).... |